Janelle Bradley

News
Zenocutuzumab Demonstrates Durable Activity in NRG1 Fusion–Positive Solid Tumors
03/31/2025
Findings from a phase 2 study show zenocutuzumab demonstrated durable clinical activity and a favorable safety profile in patients with NRG1 fusion–positive solid tumors, particularly non–small-cell lung and pancreatic cancers.
Findings from a phase 2 study show zenocutuzumab demonstrated durable clinical activity and a favorable safety profile in patients with NRG1 fusion–positive solid tumors, particularly non–small-cell lung and pancreatic cancers.
Findings from a phase 2 study...
03/31/2025
Oncology
News
Incidence and Predictors of Obinutuzumab Infusion-Related Reactions in Lymphoid Malignancies
03/31/2025
A multicenter retrospective study found that over half of patients receiving obinutuzumab experienced infusion-related reactions, with higher risk observed in those with chronic lymphocytic leukemia or elevated baseline lymphocyte counts.
A multicenter retrospective study found that over half of patients receiving obinutuzumab experienced infusion-related reactions, with higher risk observed in those with chronic lymphocytic leukemia or elevated baseline lymphocyte counts.
A multicenter retrospective...
03/31/2025
APP Institute Oncology
News
PRO-CTCAE Tool Improves Symptom Management in Head and Neck Oncology Clinic
03/28/2025
Implementation of the PRO-CTCAE tool in a head and neck oncology clinic improved symptom identification, documentation, and patient-provider communication without disrupting clinic workflow.
Implementation of the PRO-CTCAE tool in a head and neck oncology clinic improved symptom identification, documentation, and patient-provider communication without disrupting clinic workflow.
Implementation of the PRO-CTCAE...
03/28/2025
APP Institute Oncology
News
Onboarding Tool Improves Gastrointestinal Surgical Oncology APP Integration and Reduces Stress
03/26/2025
A structured onboarding tool for gastrointestinal surgical oncology advanced practice providers improved clinical knowledge, confidence, and reduced perceived stress, facilitating faster progression to independent practice.
A structured onboarding tool for gastrointestinal surgical oncology advanced practice providers improved clinical knowledge, confidence, and reduced perceived stress, facilitating faster progression to independent practice.
A structured onboarding tool for...
03/26/2025
APP Institute Oncology
Conference Coverage
Workload Index Proves Valuable in Optimizing Oncology Advanced Practitioner Resourcing
11/18/2024
Findings demonstrate the success of the workload index in supporting daily and longitudinal staffing needs as well as for operational and strategic planning and has improved advanced practitioner morale by demonstrating productivity not...
Findings demonstrate the success of the workload index in supporting daily and longitudinal staffing needs as well as for operational and strategic planning and has improved advanced practitioner morale by demonstrating productivity not...
Findings demonstrate the success...
11/18/2024
APP Institute Oncology
News
Durvalumab Added to Etoposide Plus Platinum is Not Cost-Effective for First-Line Treatment of Extensive-Stage SCLC
12/22/2021
Adding durvalumab to etoposide and platinum is not cost-effective compared with etoposide and platinum alone for patients with newly diagnosed extensive-stage SCLC from a US payer perspective.
Adding durvalumab to etoposide and platinum is not cost-effective compared with etoposide and platinum alone for patients with newly diagnosed extensive-stage SCLC from a US payer perspective.
Adding durvalumab to etoposide...
12/22/2021
Journal of Clinical Pathways
News
Long-term Outcomes of Endoscopic Therapy vs Surgical Resection for Gastrointestinal Stromal Tumors
05/04/2022
Study findings reveal no significant difference in long-term survival among patients with gastrointestinal stromal tumors receiving endoscopic therapy vs surgical resection.
Study findings reveal no significant difference in long-term survival among patients with gastrointestinal stromal tumors receiving endoscopic therapy vs surgical resection.
Study findings reveal no...
05/04/2022
Oncology
NCCN Updates Clinical Practice Guideline for Hepatobiliary Cancers
NCCN Updates Clinical Practice Guideline for Hepatobiliary Cancers
03/09/2021
NCCN released an update to its guideline for hepatobiliary cancers, featuring updates in HCC, gallbladder cancer, intrahepatic cholangiocarcinoma, and biliary tract cancer.
NCCN released an update to its guideline for hepatobiliary cancers, featuring updates in HCC, gallbladder cancer, intrahepatic cholangiocarcinoma, and biliary tract cancer.
NCCN released an update to its...
03/09/2021
Journal of Clinical Pathways
News
Impact of Updated USPSTF Prostate Cancer Screening Recommendation on Rates of PSA Testing
02/18/2022
Rates of PSA screening increased significantly following a revision to the USPSTF guideline on prostate cancer screening, according to a study published in JAMA Oncology.
Rates of PSA screening increased significantly following a revision to the USPSTF guideline on prostate cancer screening, according to a study published in JAMA Oncology.
Rates of PSA screening increased...
02/18/2022
Journal of Clinical Pathways
Conference Coverage
Triplet Therapy Improves Response, Demonstrates Acceptable Safety in Recurrent Endometrial Cancer
06/21/2022
Treatment with rucaparib, bevacizumab, and atezolizumab is feasible, demonstrating clinically meaningful improvement in response with acceptable safety for patients with recurrent endometrial cancer, according to a phase 2 trial.
Treatment with rucaparib, bevacizumab, and atezolizumab is feasible, demonstrating clinically meaningful improvement in response with acceptable safety for patients with recurrent endometrial cancer, according to a phase 2 trial.
Treatment with rucaparib,...
06/21/2022
Oncology

Upcoming Events

Psych Congress Regionals
April 3 ⁠–⁠ April 4
Advances in Inflammatory Bowel Disease Regionals
April 5 ⁠–⁠ April 6
Rx summit logo
April 21 ⁠–⁠ April 24
April 29 ⁠–⁠ April 30
Symposium on Advanced Wound Care
April 30 ⁠–⁠ May 4
Psych Congress Regionals
May 1 ⁠–⁠ May 2
May 7 ⁠–⁠ May 9
NEI Congress
May 8 ⁠–⁠ May 10
Dermatology Week
May 14 ⁠–⁠ May 16
Senior Living Executive Conference
May 19 ⁠–⁠ May 21
See Full Calendar

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2025 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use